Diagnosed at birth, phenylketonuria, or PKU, is a lifelong enzymatic deficiency that can lead to cognitive impairment if untreated. The traditional standard of care involved a protein-free diet, which most patients could not follow. Perception of PKU as simply a diet condition had become the norm, and patients were not engaging with their doctors or each other. BioMarin wanted a better way to reach patients, get them on treatment, and raise awareness of its therapy, KUVAN.
Details
Role
BioMarin fought misconceptions about PKU not only among patients but also among some doctors. The campaign aimed to galvanize patient and caregiver audiences by building community online and offline, while encouraging more active discussions with their care teams.
A disease education campaign for patients and their doctors reframed the condition as a brain disease that manifests through confusion, brain fog, irritability, and other cognitive impairments. The social and digital campaign “PKU & Me” featured PKU patients and their caregivers, tools, Facebook Live events, demand-generation functionality, dietary tips, and community-building.
Building on social’s content strategy and design language, the patient website was also an essential destination. It offered age-segmented educational content, a symptom checker, and a clinic locator to raise awareness, particularly for patients who had fallen off therapy. Most importantly, the website hosted live events where patients could connect for support and education.
PKUBrain was the initiative’s clinical arm, targeting clinicians to raise awareness of PKU’s underlying causes and symptoms. Called “Brain, Phe, Impact,” the campaign emphasized that PKU is a brain disease and stressed the urgency of diagnosing patients and starting therapy.
Clinicians who opted in to the RM program received emails highlighting clinical papers and KOL presentations, further enriching their education and brand awareness of KUVAN for prescribing to their patients.